InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the complete record of transactions filed by Rafferty Emily Ann. Officer active across 1 company, notably Evolent Health, Inc.. In total, 5 filings have been recorded. Breakdown: 0 buy · 2 sells. Total volume traded: €442k. Activity tracked since 15 August 2023. The latest transaction was filed on 1 March 2025 (Retenue fiscale). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations
Rafferty Emily Ann is Chief Operating Officer at Evolent Health, Inc. Across 5 total filings, the 5 sampled filings run from 2023-08-17 to 2025-03-04 and show EUR 0 in purchases and EUR 442337 in sales, with the modal transaction nature listed as Retenue fiscale.